CA
NZ
UK
AU
IND
US
• FDA Clearance Secured: Tenon Medical (NASDAQ: TNON) received 510(k) clearance for its Catamaran SI Joint Fusion System from the U.S. Food and Drug Administration.
• 37% Share Price Decline on Dilution: Shares fell 37% to $3.22 following the registered direct offering announcement, reflecting the significant dilutive impact on existing shareholders.
• $15 Million Raised: Elicio Therapeutics (NASDAQ: ELTX) closed a registered direct offering of 4.38 million shares, raising approximately $15 million gross.
• 770,000 Shares Purchased at $0.1956: The company acquired 770,000 additional shares through open market purchases at an average cost of approximately $0.1956 per share.
• Late-Breaking Selection: Tenax Therapeutics (NASDAQ: TENX) will present Phase 3 LEVEL trial data at a Late-Breaking Clinical Science session at ESC Congress 2026 in Munich.
• Late-Breaking ESC 2026 Session Selected: Phase 3 LEVEL trial data for TNX-103 was selected for a Late-Breaking Clinical Science session at the ESC Congress 2026 in Munich on August 29, 2026.
• Getty Images abandoned a $3.7 billion deal with Shutterstock after the UK regulator demanded a divestiture.
• Subsea AI technology is projected to achieve 10-20x growth by 2030, reshaping a $36 billion market.
• SurgePays (NASDAQ: SURG) removes $50 million aggregate minimum spend requirement in amended AT&T wholesale agreement.
• Common stock of New Slider HoldCo has a par value of $1.00 per share.
Please wait processing your request...